William Ackman · activist-deck
Allergan, Inc. (AGN)
110 pages · 0 arc beats · 2 loops
Allergan, Inc. (AGN)
William Ackman · 2014-04 arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
15101520253035404550556065707580859095100105110
Deck intelligence map
1 coverage by narrative range · generated from this deck JSON
Narrative range 110 total
Metadata
Components
Metrics
Tools
Frameworks
Beats
Loops
Whole deck 110 slides 100% 110/110 slides 100% 110/110 slides · 533 hits — 0/110 slides
38.2% 42/110 slides · 46 hits 40.9% 45/110 slides · 46 hits — 0/110 slides
10% 11/110 slides Slide inventory
110 every slide · same image gating as the playbook
06
The slide contains a redundant, faint copy of the text at the bottom center, likely an artifact of the document generation process.other
09
The slide uses a red callout box to emphasize the core thesis and red 'X' icons to list specific industry pain points.name_villain
11
The chart highlights the correlation between CEO tenure/acquisitions and stock performance.illustrate_case
Open slide detailLoop · Tale Two Worlds
12
The slide serves as a reference or authority citation for the management philosophy being advocated.cite_precedent
Open slide detailLoop · Tale Two Worlds
13
The slide uses the 'Outsiders' framework to establish a benchmark for Valeant's management philosophy.cite_precedent
Open slide detailLoop · Tale Two Worlds
14
The slide uses a classic 'authority-citation' framework to validate the CEO's management style by aligning it with the principles of successful 'Outsider' CEOs.cite_precedent
Open slide detailLoop · Tale Two Worlds
15
The slide highlights the inclusion of Mike Pearson (Valeant) in a list of 'Outsider' CEOs, likely to draw a comparison or contrast.cite_precedent
Open slide detailLoop · Tale Two Worlds
19
This slide outlines the core pillars of the activist investor's thesis for Valeant Pharmaceuticals.summarize
20
The slide emphasizes connections to Bill Ackman and Mike Pearson, likely to establish credibility or suggest conflicts/alliances.introduce_nominees
23
The chart uses a bridge-like structure to reclassify 85% of revenue as 'durable' by excluding the 15% 'Patent Cliff Rx' portion.present_solution
28
The slide highlights the composition of Valeant's business segments and justifies their attractiveness.size_opportunity
29
The slide uses a dot-matrix to visualize market presence by product type and region.decompose_segments
31
The slide highlights that the durable business represents ~85% of total sales.analyze_data
34
The slide uses media headlines as evidence of the financial risk associated with traditional R&D models.cite_precedent
38
The slide uses a waterfall-style comparison to illustrate margin efficiency.compare_peers
42
The slide contains two green callout boxes containing quotes, followed by the attribution.cite_precedent
44
The slide uses a direct quote to frame the company's internal culture as a strategic choice.establish_context
46
The slide uses a waterfall-style visual to contrast cost components.compare_peers
48
The slide uses a simple numerical example to illustrate the 'valuation trap' of consolidated growth metrics.frame_problem
50
Uses a conceptual line chart to explain the 'patent cliff' impact on reported growth.preempt_rebuttal
51
The table highlights the performance of 'Total Product Sales' across different periods.analyze_data
55
The slide uses a table to show the vesting schedule of performance share units (PSUs) based on annualized Total Shareholder Return (TSR).expose_contradiction
56
The slide uses the 3G Capital case study as a precedent to validate Valeant's management philosophy.cite_precedent
60
The slide uses a visual bracket to emphasize the cumulative difference between the two metrics over the three-year period.expose_contradiction
61
The slide highlights specific accounting adjustments used by Valeant to inflate earnings metrics.analyze_data
62
The slide uses a bridge-style reconciliation table to justify non-GAAP metrics.analyze_data
63
The slide uses a table to contrast GAAP accounting practices with the author's economic view of the company's performance.expose_contradiction
65
The slide uses a dual-axis chart to correlate share price (line) with volume (bars) and Pershing Square's specific purchase activity (dark bars).preempt_rebuttal
Open slide detailLoop · Cost Of Inaction
66
This slide provides factual evidence regarding the accumulation of an economic stake and the subsequent market reaction.analyze_data
Open slide detailLoop · Cost Of Inaction
67
This slide is likely part of a legal or regulatory filing (SEC) documenting market activity.expose_contradiction
Open slide detailLoop · Cost Of Inaction
72
The slide uses a 'drill-down' visual technique to show the composition of the 'Durable' segment.summarize
73
The slide highlights that the analyst's 6-8% growth estimate is a slight discount to management's own projections.analyze_data
74
Uses red 'X' icons to emphasize the lack of comparability across four industry segments.compare_peers
77
The slide uses a comparison framework to justify valuation multiples by drawing parallels to a high-performing consumer sector.compare_peers
79
The chart uses a floating bar format to show ranges for three different comparable categories.show_valuation_bridge
80
The slide details three specific conservative assumptions regarding life-cycle management, post-patent revenue, and cost variability.summarize
81
The slide outlines the assumptions (10% discount rate, 10-year life, 0-5% growth) and presents a sensitivity table for DCF multiples.analyze_data
82
The table uses a weighted average approach based on earnings contribution to derive the base business multiple.show_valuation_bridge
84
Features logos of Danaher, Liberty Media, ABInBev, and Jarden Corporation as examples of platform businesses.establish_context
85
The chart uses a timeline-based annotation style to correlate M&A activity with stock performance.illustrate_case
86
The slide uses 'The Outsiders' book principles as a framework for evaluating Jarden's management success.present_framework
87
This slide serves as a historical context piece for an activist investor's thesis regarding a specific executive's track record.establish_context
88
The slide uses callout boxes to correlate specific corporate milestones with stock price movements.illustrate_case
89
Uses a binary choice structure to frame the valuation argument.expose_contradiction
90
The slide uses a custom qualitative scoring framework represented by pie charts.present_framework
91
The slide highlights specific financial and strategic pitfalls such as overpaying for acquisitions and focusing on GAAP earnings over economic earnings.name_villain
93
The slide uses a before-after framing to demonstrate that realized synergies consistently exceeded initial announcements.expose_contradiction
94
The slide lists 36 companies in the table, but the header text mentions 58 companies. The data is sourced from Capital IQ as of 4/21/2014.size_opportunity
95
The table shows ranks 37-58, implying this is part of a larger list. Data source is Capital IQ.size_opportunity
96
Uses a visual dot-fill system to represent high vs low value indicators.present_framework
97
The slide uses a pro-forma bridge to justify the acquisition price and expected returns.show_valuation_bridge
98
The slide uses a hypothetical scenario to justify a valuation premium based on asset acquisition scale.show_valuation_bridge
99
The chart illustrates the expansion of the P/E multiple from 2008 to 2014.quantify_opportunity
100
The slide consists of a single callout box containing the core investment thesis.present_solution
102
The slide uses a contrast-pair structure to highlight the perceived reliability of Valeant's synergy track record versus the uncertainty of standalone Allergan'compare_peers
103
The slide uses a calculation table to demonstrate the break-even point for the transaction value.show_valuation_bridge
106
The slide justifies non-GAAP adjustments by arguing that GAAP accounting conventions for acquisitions do not reflect the underlying economic reality of the busianalyze_data
107
This slide is part of a larger activist presentation critiquing Valeant's accounting practices.expose_contradiction
108
This slide attempts to normalize earnings by removing costs the company deems non-recurring.preempt_rebuttal
109
The slide uses two distinct sections to frame the argument about tax rate accuracy and sustainability.summarize
110
The slide includes a summary table of undiscounted cash flows and a detailed table of discounted cash flows at a 10% discount rate.show_valuation_bridge